Jay Grotas in Brooklyn, New York

Home New York Brooklyn

Jay Grotas has Urology as his primary medical specialty. Their primary office is: 3080 Brighton 13 St in Brooklyn, New York. They attended Sorry, his university is not listed and graduated in 1974 (around 50 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Jay Grotas Office Phone and Directions

Jay Grotas
3080 Brighton 13 St
Brooklyn, New York 11235
718-743-0101

Patient Ratings
Please rate your experience with Jay Grotas below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 718-743-0101

Enter a starting address:

Healthcare Info for Jay Grotas

Medical School: Sorry, his university is not listed
Graduation Year: 1974
The Primary Medical Specialty for Jay Grotas is listed as: Urology
Approximate Years of Experience: 50
PAC (PECOS ID)#: 8820132566
NPI #: 1548277221
NPI Created On: 08/02/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 208800000X
License Number:
124807
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Assessment of muscle signal of pelvic nerves
Ultrasound behind abdominal cavity
Ultrasound of pelvis
Ultrasound of scrotum
Ultrasound of rectum
Automated urinalysis test
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 850166735

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Gastroenterology

Name of Drug #1: XIFAXAN

Open Associated Drug #1: 65649-303-02